Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse

Hepatology

Volumn 31, Issue 2, 2000, Pages 480-487

  Böcher, Wulf Otto ^a,b   Galun, Eithan ^c   Marcus, Hadar ^a   Daudi, Nili ^c   Terkieltaub, Dov ^d   Shouval, Daniel ^c   Löhr, Hanns Friedrich ^b   Reisner, Yair ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d Xenograft Technologies Ltd   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 2; NEUTRALIZING ANTIBODY; TETANUS TOXOID; VIRUS DNA;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DISEASE CARRIER; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VACCINATION;

EID: 0033966710     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510310231     Document Type: Article

References (12)

1. Lau JY, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet 1993;342:1335-1340.
2. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995;13:29-60.
3. Löhr HF, Gerken G, Schlicht HJ, Meyer zum Büschenfelde KH, Fleischer B. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B. J Infect Dis 1993;168:1133-1139.
4. Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T, Cavalli A, et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990;145:3442-3449.
5. Tsai SL, Chen PJ, Lai MY, Yang PM, Sung JL, Huang JH, Hwang LH, et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest 1992;89:87-96.
6. Rehermann B, Fowler P, Sidney J, Person J, Redeker A, Brown M, Moss B, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995;181:1047-1058.
7. Böcher WO, Herzog-Hauff S, Meyer zum Büschenfelde KH, Löhr HF. Kinetics of hepatitis B surface (HBs) specific immune responses in acute and chronic hepatitis B or after HBs vaccination. Stimulation of the in vitro antibody response by interferon-γ. HEPATOLOGY 1999;29:238-244.
8. Maruyama T, McLachlan A, lino S, Koike K, Kurokawa K, Milich DR. The serology of chronic hepatitis B infection revisited. J Clin Invest 1993;91:2586-2595.
9. Wainwright RB, McMahon BJ, Bulkow LR, Hall DB, Fitzgerald MA, Harpster AP, Hadler SC, et al. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. JAMA 1989;261:2362-2366.
10. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993;329:1842-1847.
11. Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH. Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol 1984;52:396-402.
12. Michalak TI, Lau JY, McFarlane BM, Alexander GJ, Eddleston AL, Williams R. Antibody-directed complement-mediated cytotoxicity to hepatocytes from patients with chronic hepatitis B. Clin Exp Immunol 1995;100:227-232.